Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

has been completed. VOWST is not intended for treatment of C. diff infection. Please see the full U.S. Prescribing Information for the complete Indication and Important Safety Information below. This press release contains forward-looking...

Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

has been dosed in an investigator initiated trial (IIT) using ImmuXell’s TCR-T cell therapy manufactured on Ori’s IRO® platform. The IIT is aiming to evaluate ImmuXell’s TCR-T therapy in patients with solid tumors harboring KRAS G12V mutations,...

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

continues to support these efforts through initiatives aimed at strengthening regional innovation and manufacturing platforms, enhancing regulatory systems, and expanding joint procurement mechanisms across the region." Lucía Ayala, President of...

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

study. "The 72- and 124-week open-label extension studies, which over 90% of participants completed, provide further information on lerodalcibep’s longer term robust and sustained reductions in LDL-C and other lipids and lipoproteins, safety and...

Digi-Tech Pharma & AI Conference 2026

technologies and practical solutions. In this 8th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial...

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and...

Hologic to Present New Data Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions

only genomic assay shown to predict who is likely to benefit from extended endocrine therapy beyond five years.2,3 More information on these findings will be presented at the 2026 ASCO Annual Meeting on June 1. The data come from a new analysis of...

Aspera Biomedicines launched its second ADAR1p150 crystallization to the ISS aboard SpaceX CRS-34

as part of a NASA InSPA Phase 2 award to further elucidate the mechanism of action of Rebecsinib and to develop an oral formulation for clinical trials in a broad array of advanced malignancies,” said Dr. Catriona Jamieson, Founder and Board Member...

Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio

Aliya PEF while preserving the biologic mechanism, procedural consistency, and workflow integration that define our platform." About Aliya® PEF Energy Aliya EX delivers high-voltage, short-duration electrical energy locally to induce non-thermal...

Peter Menziuso named EVP and President of BD Interventional

medical affairs. Throughout his career, Menziuso has been recognized for strengthening market leadership, building high‑performing teams and translating strategy into sustained performance through commercial rigor and operational excellence. His...

A new real-world case series examines re-induction with ADSTILADRIN in clinical practice

been reported. “These new data add to the growing body of real-world evidence generated in urology practices and help inform how re-induction with ADSTILADRIN is being evaluated outside of the controlled clinical trial setting, particularly in a...

Biohack skin longevity with Futurecode Booster

The concept of biohacking often brings to mind performance tracking and high-tech optimization – but at its core, it's a mindset grounded in understanding how the body functions and supporting it to work more efficiently. From adding collagen to...

Pathobiology 2026

All other abstracts will be scheduled into poster sessions that will be held in late afternoon with no competing platform sessions to ensure that all attendees can participate in the poster discussions. Further, each poster session will be preceded...

IMFINZI plus neoadjuvant EV improved survival outcomes in muscle-invasive bladder cancer in the Phase III VOLGA trial

trend for OS; however, the OS data were not statistically significant at this planned interim analysis and will be formally reassessed at a subsequent analysis. Approximately one in four patients with bladder cancer has muscle-invasive disease,...

Neurocritical care leaders will discuss NPi pupillometry in NeurOptics sessions at AACN NTI 2026.

membrane oxygenation (ECMO) intervention. "Pupillary assessment is one of the key neurologic checks we can perform quickly and repeatedly at the bedside, but the traditional penlight exam has important limitations," says Olson. "NPi pupillometry...

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

to the function of tissues, organs, and physiological systems, influencing metabolism, immune function, and physical performance. Tetraselmis chuii was first identified in the 1950s and has long been used in aquaculture due to its rich nutritional...

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

growth initiatives, building strong partnerships with global pharmaceutical companies, and enhancing organizational performance across the business. In her role, McCullough Wood will lead Avid's global commercial organization, including business...

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

and supporting medical teams with the purpose of achieving superior outcomes for patients and their families. For more information please Visit www.partnertx.com.

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL. Restoration (BEAR®) Implant, announced Jamal Rushdy has been selected as the...

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

vials. “We are proud to continue expanding our portfolio with the addition of Tranexamic Acid in a ready-to-use format,” said Jeff Yordon, Co-Founder and CEO of Avenacy. “This presentation enables healthcare providers to deliver safe and efficient...